Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Return on Invested Capital [ROIC] (2016 - 2019)

Updated

Aptevo Therapeutics (APVO) reported Return on Invested Capital [ROIC] of -62.08% for Q3 2019.

Analysis

Aptevo Therapeutics (APVO) Return on Invested Capital [ROIC] (2016 - 2019) Analysis & Trends

For FY2017, Aptevo Therapeutics posted Return on Invested Capital [ROIC] of -37.00%.

  • The Q3 2019 figure ranks as the highest quarterly Return on Invested Capital [ROIC] since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -62.08%
Dec 31, 2017 -30.12%
Sep 30, 2017 -39.94%
Jun 30, 2017 -148.72%
Mar 31, 2017 -148.72%
Dec 31, 2016 -148.91%
API Access

Aptevo Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=APVO&period=max&api_key=YOUR_API_KEY